Biomarker repurposing: opportunities and challenges in the evolving field of laboratory medicine.
作者信息
Gruson Damien, Menghoun Nassiba, Pouleur Anne-Catherine, Bayes Genis Antoni
机构信息
Department of Laboratory Medicine, Cliniques Universitaires St-Lux, Université Catholique de Louvain, Brussels, Belgium.
Pôle de recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc and Université Catholique de Louvain, Brussels, Belgium.
出版信息
Adv Lab Med. 2024 Dec 31;6(2):221-223. doi: 10.1515/almed-2024-0158. eCollection 2025 Jun.
Abstract
摘要
相似文献
1
Biomarker repurposing: opportunities and challenges in the evolving field of laboratory medicine.生物标志物的重新利用：检验医学不断发展领域中的机遇与挑战。
Adv Lab Med. 2024 Dec 31;6(2):221-223. doi: 10.1515/almed-2024-0158. eCollection 2025 Jun.
2
Usefulness of Antigen Carbohydrate 125 and N-Terminal Pro-B-Type Natriuretic Peptide for Assessing Congestion in Chronic Heart Failure: Insights from the CARDIOREN Registry.抗原碳水化合物 125 和 N 端脑利钠肽前体在评估慢性心力衰竭充血中的作用：来自 CARDIOREN 登记研究的见解。
Cardiorenal Med. 2024;14(1):543-555. doi: 10.1159/000541324. Epub 2024 Sep 5.
3
Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.CA125 在心力衰竭恶化中的临床作用：BIOSTAT-CHF 研究的亚组分析。
JACC Heart Fail. 2020 May;8(5):386-397. doi: 10.1016/j.jchf.2019.12.005. Epub 2020 Mar 11.
4
Carbohydrate antigen 125 in congestive heart failure: ready for clinical application?充血性心力衰竭中的糖类抗原125：准备好用于临床应用了吗？
Front Oncol. 2023 Oct 31;13:1161723. doi: 10.3389/fonc.2023.1161723. eCollection 2023.
5
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.抗原碳水化合物 125 作为心力衰竭的生物标志物：叙述性综述。
Eur J Heart Fail. 2021 Sep;23(9):1445-1457. doi: 10.1002/ejhf.2295. Epub 2021 Jul 20.
6
Carbohydrate Antigen 125: A Biomarker at the Crossroads of Congestion and Inflammation in Heart Failure.糖类抗原125：心力衰竭中充血与炎症交叉点的生物标志物
Card Fail Rev. 2021 Jun 12;7:e19. doi: 10.15420/cfr.2021.22. eCollection 2021 Mar.
7
Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure.CA125 与 NT-proBNP 用于评估急性心力衰竭患者充血的比较。
Med Clin (Barc). 2021 Jun 25;156(12):589-594. doi: 10.1016/j.medcli.2020.05.063. Epub 2020 Sep 18.
8
Carbohydrate antigen 125 predicts pulmonary congestion in patients with ST-segment elevation myocardial infarction.糖类抗原125可预测ST段抬高型心肌梗死患者的肺充血情况。
Braz J Med Biol Res. 2019 Dec 5;52(12):e9124. doi: 10.1590/1414-431X20199124. eCollection 2019.
9
Serum levels of carbohydrate antigen 125 in patients with heart failure and obstructive sleep apnea syndrome: a retrospective analysis.心力衰竭合并阻塞性睡眠呼吸暂停综合征患者血清糖类抗原125水平：一项回顾性分析
Cardiovasc Diagn Ther. 2023 Dec 15;13(6):994-1002. doi: 10.21037/cdt-23-323. Epub 2023 Dec 6.
10
Utility of the Biomarker CA125 in the Diagnosis of Cellular Rejection in Allogeneic Heart Transplantation.生物标志物 CA125 在同种异体心脏移植中细胞排斥诊断中的应用。
Transplant Proc. 2021 Nov;53(9):2721-2723. doi: 10.1016/j.transproceed.2021.07.058. Epub 2021 Sep 30.
本文引用的文献
1
Multi-bioinformatics revealed potential biomarkers and repurposed drugs for gastric adenocarcinoma-related gastric intestinal metaplasia.多组学分析揭示胃腺癌相关肠上皮化生的潜在生物标志物和再利用药物。
NPJ Syst Biol Appl. 2024 Nov 4;10(1):127. doi: 10.1038/s41540-024-00455-0.
2
Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure.利钠肽在心力衰竭诊断中的知晓率、可及性及应用情况。
ESC Heart Fail. 2025 Feb;12(1):54-59. doi: 10.1002/ehf2.14825. Epub 2024 Sep 4.
3
Teaching an old drug new tricks: Regulatory insights for the repurposing of hemin in cardiovascular disease.旧药新用：调控视阈下血红素在心血管疾病中的再利用。
Pharmacol Res Perspect. 2024 Aug;12(4):e1225. doi: 10.1002/prp2.1225.
4
Artificial intelligence in drug repurposing for rare diseases: a mini-review.人工智能在罕见病药物再利用中的应用：一篇综述
Front Med (Lausanne). 2024 May 22;11:1404338. doi: 10.3389/fmed.2024.1404338. eCollection 2024.
5
Circulating SMRP and CA-125 before and after pleurectomy decortication for pleural mesothelioma.胸腔镜胸膜剥脱术治疗胸膜间皮瘤前后循环 SMRP 和 CA-125。
Thorac Cancer. 2024 May;15(15):1237-1245. doi: 10.1111/1759-7714.15264. Epub 2024 Apr 16.
6
The multidimensional value of natriuretic peptides in heart failure, integrating laboratory and clinical aspects.利钠肽在心力衰竭中的多维价值，整合实验室和临床方面。
Crit Rev Clin Lab Sci. 2024 Sep;61(6):458-472. doi: 10.1080/10408363.2024.2319578. Epub 2024 Mar 25.
7
Carbohydrate antigen 125: a useful marker of congestion, fibrosis, and prognosis in heart failure with preserved ejection fraction.糖类抗原 125：心力衰竭伴射血分数保留的标志物，可用于评估充血、纤维化和预后。
ESC Heart Fail. 2024 Jun;11(3):1493-1505. doi: 10.1002/ehf2.14699. Epub 2024 Feb 9.
8
Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.新诊断及复发的上皮性卵巢癌：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2023 Oct;34(10):833-848. doi: 10.1016/j.annonc.2023.07.011. Epub 2023 Aug 17.
9
CA125, Galectin-3 and FGF-23 are interrelated in heart failure with reduced ejection fraction.在射血分数降低的心力衰竭中，CA125、半乳糖凝集素-3和FGF-23相互关联。
EJIFCC. 2023 Jul 10;34(2):103-109. eCollection 2023 Jul.
10
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.抗原碳水化合物 125 作为心力衰竭的生物标志物：叙述性综述。
Eur J Heart Fail. 2021 Sep;23(9):1445-1457. doi: 10.1002/ejhf.2295. Epub 2021 Jul 20.
Zotero 插件